Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | OCGN |
---|---|---|
09:32 ET | 34845 | 0.3931 |
09:33 ET | 6292 | 0.3901 |
09:35 ET | 2839 | 0.394 |
09:37 ET | 29153 | 0.3907 |
09:39 ET | 11553 | 0.3907 |
09:42 ET | 3554 | 0.394 |
09:46 ET | 2457 | 0.392 |
09:48 ET | 3546 | 0.394 |
09:50 ET | 1930 | 0.390201 |
09:51 ET | 1100 | 0.390101 |
09:53 ET | 800 | 0.3901 |
09:55 ET | 4147 | 0.3932 |
09:57 ET | 7300 | 0.3901 |
10:02 ET | 800 | 0.3921 |
10:04 ET | 1359 | 0.3939 |
10:06 ET | 1699 | 0.3921 |
10:08 ET | 2494 | 0.3921 |
10:09 ET | 100 | 0.39305 |
10:11 ET | 7950 | 0.3924 |
10:15 ET | 16507 | 0.3921 |
10:18 ET | 3633 | 0.3921 |
10:20 ET | 4777 | 0.3922 |
10:22 ET | 5800 | 0.3921 |
10:24 ET | 3900 | 0.3908 |
10:26 ET | 5403 | 0.3915 |
10:27 ET | 7737 | 0.391 |
10:29 ET | 10959 | 0.3911 |
10:31 ET | 1189 | 0.3909 |
10:33 ET | 2000 | 0.3917 |
10:36 ET | 300 | 0.3909 |
10:38 ET | 7803 | 0.391 |
10:40 ET | 100 | 0.39105 |
10:42 ET | 1100 | 0.39105 |
10:44 ET | 2455 | 0.3916 |
10:45 ET | 6558 | 0.3917 |
10:47 ET | 2906 | 0.39145 |
10:49 ET | 1791 | 0.3914 |
10:51 ET | 8000 | 0.3914 |
10:54 ET | 300 | 0.3915 |
10:56 ET | 900 | 0.3914 |
10:58 ET | 2318 | 0.3915 |
11:00 ET | 12087 | 0.3915 |
11:02 ET | 300 | 0.3915 |
11:03 ET | 500 | 0.3915 |
11:05 ET | 4400 | 0.3914 |
11:07 ET | 2292 | 0.391406 |
11:09 ET | 4398 | 0.3914 |
11:12 ET | 1100 | 0.3914 |
11:14 ET | 15348 | 0.3913 |
11:18 ET | 2485 | 0.3913 |
11:20 ET | 200 | 0.3913 |
11:21 ET | 10376 | 0.3914 |
11:23 ET | 1102 | 0.3915 |
11:25 ET | 5650 | 0.3913 |
11:27 ET | 341 | 0.3915 |
11:30 ET | 4833 | 0.3914 |
11:34 ET | 700 | 0.3916 |
11:36 ET | 720 | 0.3916 |
11:41 ET | 1969 | 0.3915 |
11:43 ET | 1919 | 0.3915 |
11:45 ET | 2183 | 0.3915 |
11:48 ET | 3700 | 0.3915 |
11:50 ET | 35253 | 0.3905 |
11:52 ET | 200 | 0.390951 |
11:54 ET | 2304 | 0.390078 |
11:56 ET | 9298 | 0.3901 |
11:57 ET | 15367 | 0.3897 |
11:59 ET | 300 | 0.3897 |
12:01 ET | 3297 | 0.3895 |
12:03 ET | 10350 | 0.3895 |
12:06 ET | 200 | 0.3895 |
12:10 ET | 700 | 0.3898 |
12:14 ET | 230 | 0.3896 |
12:15 ET | 815 | 0.3895 |
12:17 ET | 900 | 0.3895 |
12:19 ET | 800 | 0.3897 |
12:21 ET | 328 | 0.3894 |
12:24 ET | 857 | 0.3896 |
12:26 ET | 300 | 0.3896 |
12:28 ET | 18558 | 0.3897 |
12:30 ET | 1668 | 0.3897 |
12:32 ET | 11950 | 0.3909 |
12:33 ET | 923 | 0.3897 |
12:35 ET | 700 | 0.3899 |
12:37 ET | 100 | 0.39 |
12:39 ET | 103 | 0.38961 |
12:42 ET | 100 | 0.39 |
12:44 ET | 2400 | 0.3896 |
12:46 ET | 500 | 0.3897 |
12:48 ET | 400 | 0.3896 |
12:50 ET | 6874 | 0.3895 |
12:51 ET | 1600 | 0.38955 |
12:53 ET | 670 | 0.3897 |
12:55 ET | 300 | 0.3896 |
12:57 ET | 1339 | 0.389699 |
01:00 ET | 2351 | 0.3898 |
01:02 ET | 4056 | 0.3898 |
01:04 ET | 600 | 0.38975 |
01:06 ET | 200 | 0.3898 |
01:08 ET | 200 | 0.3898 |
01:09 ET | 300 | 0.3897 |
01:11 ET | 1875 | 0.3897 |
01:13 ET | 539 | 0.3898 |
01:15 ET | 1000 | 0.3898 |
01:18 ET | 32461 | 0.3898 |
01:20 ET | 2048 | 0.3898 |
01:22 ET | 1226 | 0.3909 |
01:24 ET | 1665 | 0.3909 |
01:26 ET | 675 | 0.39001 |
01:27 ET | 400 | 0.3901 |
01:29 ET | 1323 | 0.3909 |
01:31 ET | 5618 | 0.3902 |
01:33 ET | 1000 | 0.3907 |
01:36 ET | 1164 | 0.3907 |
01:38 ET | 100 | 0.3907 |
01:40 ET | 2800 | 0.390634 |
01:42 ET | 1049 | 0.3904 |
01:44 ET | 530 | 0.390449 |
01:45 ET | 1000 | 0.3906 |
01:47 ET | 359 | 0.3907 |
01:49 ET | 3000 | 0.3902 |
01:51 ET | 100 | 0.3901 |
01:54 ET | 500 | 0.390199 |
01:56 ET | 626 | 0.3903 |
01:58 ET | 3000 | 0.3902 |
02:00 ET | 468 | 0.3902 |
02:02 ET | 500 | 0.3903 |
02:03 ET | 400 | 0.390199 |
02:05 ET | 300 | 0.3901 |
02:07 ET | 200 | 0.3901 |
02:09 ET | 900 | 0.3901 |
02:12 ET | 11400 | 0.3902 |
02:14 ET | 844 | 0.390137 |
02:16 ET | 300 | 0.3902 |
02:18 ET | 400 | 0.3902 |
02:20 ET | 5030 | 0.3901 |
02:21 ET | 500 | 0.39 |
02:23 ET | 1809 | 0.3902 |
02:25 ET | 775 | 0.39005 |
02:27 ET | 3164 | 0.39 |
02:30 ET | 100 | 0.3901 |
02:32 ET | 300 | 0.39005 |
02:34 ET | 300 | 0.3901 |
02:36 ET | 2200 | 0.39 |
02:38 ET | 1528 | 0.3899 |
02:39 ET | 300 | 0.3899 |
02:41 ET | 412 | 0.3899 |
02:43 ET | 500 | 0.3899 |
02:45 ET | 4982 | 0.39 |
02:48 ET | 1344 | 0.3901 |
02:50 ET | 1004 | 0.3903 |
02:52 ET | 1575 | 0.3903 |
02:54 ET | 360 | 0.3901 |
02:56 ET | 3400 | 0.39 |
02:57 ET | 841 | 0.39 |
02:59 ET | 100 | 0.3901 |
03:01 ET | 250 | 0.3904 |
03:03 ET | 4470 | 0.3901 |
03:06 ET | 929 | 0.39005 |
03:08 ET | 2500 | 0.3901 |
03:10 ET | 2100 | 0.390001 |
03:12 ET | 300 | 0.390099 |
03:14 ET | 7700 | 0.3902 |
03:15 ET | 3995 | 0.39 |
03:17 ET | 2983 | 0.39 |
03:19 ET | 2692 | 0.3899 |
03:21 ET | 400 | 0.39 |
03:24 ET | 400 | 0.39 |
03:26 ET | 35999 | 0.3888 |
03:28 ET | 9068 | 0.3883 |
03:30 ET | 1335 | 0.3883 |
03:32 ET | 4684 | 0.3884 |
03:33 ET | 8906 | 0.388701 |
03:35 ET | 5285 | 0.3891 |
03:37 ET | 2084 | 0.388401 |
03:39 ET | 14362 | 0.3885 |
03:42 ET | 21634 | 0.3891 |
03:44 ET | 7997 | 0.3889 |
03:46 ET | 946 | 0.3889 |
03:48 ET | 1368 | 0.3888 |
03:50 ET | 322 | 0.38885 |
03:51 ET | 3451 | 0.3889 |
03:53 ET | 1883 | 0.3889 |
03:55 ET | 4360 | 0.3889 |
03:57 ET | 2600 | 0.3884 |
04:00 ET | 12562 | 0.3886 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Ocugen Inc | 99.7M | -1.2x | --- |
Vaxxinity Inc | 98.1M | -1.5x | --- |
Shattuck Labs Inc | 100.7M | -1.1x | --- |
Genenta Science SPA | 95.1M | -6.8x | --- |
Immix Biopharma Inc | 95.4M | -5.2x | --- |
GlycoMimetics Inc | 103.7M | -2.5x | --- |
Ocugen, Inc. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing gene and cell therapies, biologics, and vaccines that improve health for patients across the globe. The Company's technology pipeline includes modifier gene therapy platform, regenerative medicine cell therapy platform, and biologic therapies for retinal diseases. It is developing COVAXIN, which is a whole-virion inactivated intramuscular COVID-19 vaccine candidate for the North American market. It is also developing a inhaled mucosal vaccine platform, which includes OCU500, a bivalent COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and bivalent COVID-19 vaccine. Its modifier gene therapy platform is focused on addressing various retinal diseases, including retinitis pigmentosa (RP), Leber congenital amaurosis (LCA), and Stargardt disease, with a single mutation-agnostic therapy.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $99.7M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 256.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 3.63 |
EPS | $-0.32 |
Book Value | $0.38 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.